NC
IDXX icon

NewSquare Capital’s Idexx Laboratories IDXX Stock Holding History

NewSquare Capital’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-75
Closed -$40.2K – 671
2025
Q2 		$40.2K Buy
75
+35
+88% +$16.7K ﹤0.01% 323
2025
Q1 		$16.8K Buy
40
+33
+471% +$14.3K ﹤0.01% 405
2024
Q4 		$2.89K Buy
+7
New +$3.07K ﹤0.01% 455
2023
Q3 		– Sell
-2
Closed -$1K – 728
2023
Q2 		$1K Hold
2
– – ﹤0.01% 610
2023
Q1 		$1K Hold
2
– – ﹤0.01% 652
2022
Q4 		$816 Buy
+2
New +$776 ﹤0.01% 603

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

NewSquare Capital's IDXX Position: Q3 2025 in Review

NewSquare Capital sold out of Idexx Laboratories (IDXX) in Q3 2025, closing a stake of 75 shares — an estimated $40.2K sold.

NewSquare Capital first reported a position in IDXX in Q4 2022 and held it in 6 quarters. The position peaked at $40.2K in Q2 2025. 1,303 funds tracked by Wall St. Rank hold IDXX as of Q3 2025.

  • NewSquare Capital reported no remaining Idexx Laboratories position as of Q3 2025 after selling out during the quarter.
  • NewSquare Capital sold 75 Idexx Laboratories shares in Q3 2025, an estimated $40.2K.
  • NewSquare Capital first reported a position in Idexx Laboratories in Q4 2022 and held it in 6 quarters.
  • NewSquare Capital's Idexx Laboratories position peaked at $40.2K in Q2 2025.
  • 1,303 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2025.

Based on NewSquare Capital's 13F filing for Q3 2025, filed 12 Nov 2025.